1. Home
  2. TELA vs LOAN Comparison

TELA vs LOAN Comparison

Compare TELA & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELA
  • LOAN
  • Stock Information
  • Founded
  • TELA 2012
  • LOAN 1989
  • Country
  • TELA United States
  • LOAN United States
  • Employees
  • TELA N/A
  • LOAN N/A
  • Industry
  • TELA Medical/Dental Instruments
  • LOAN Real Estate Investment Trusts
  • Sector
  • TELA Health Care
  • LOAN Real Estate
  • Exchange
  • TELA Nasdaq
  • LOAN Nasdaq
  • Market Cap
  • TELA 47.1M
  • LOAN 51.9M
  • IPO Year
  • TELA 2019
  • LOAN 1999
  • Fundamental
  • Price
  • TELA $1.15
  • LOAN $4.64
  • Analyst Decision
  • TELA Buy
  • LOAN
  • Analyst Count
  • TELA 3
  • LOAN 0
  • Target Price
  • TELA $3.42
  • LOAN N/A
  • AVG Volume (30 Days)
  • TELA 313.6K
  • LOAN 44.2K
  • Earning Date
  • TELA 11-13-2025
  • LOAN 10-24-2025
  • Dividend Yield
  • TELA N/A
  • LOAN 10.20%
  • EPS Growth
  • TELA N/A
  • LOAN N/A
  • EPS
  • TELA N/A
  • LOAN 0.46
  • Revenue
  • TELA $77,055,000.00
  • LOAN $7,138,128.00
  • Revenue This Year
  • TELA $25.72
  • LOAN N/A
  • Revenue Next Year
  • TELA $22.03
  • LOAN $4.47
  • P/E Ratio
  • TELA N/A
  • LOAN $9.74
  • Revenue Growth
  • TELA 12.24
  • LOAN N/A
  • 52 Week Low
  • TELA $0.86
  • LOAN $4.29
  • 52 Week High
  • TELA $3.20
  • LOAN $6.05
  • Technical
  • Relative Strength Index (RSI)
  • TELA 44.20
  • LOAN 39.94
  • Support Level
  • TELA $1.01
  • LOAN $4.41
  • Resistance Level
  • TELA $1.25
  • LOAN $4.63
  • Average True Range (ATR)
  • TELA 0.13
  • LOAN 0.16
  • MACD
  • TELA 0.01
  • LOAN -0.01
  • Stochastic Oscillator
  • TELA 57.50
  • LOAN 49.30

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

Share on Social Networks: